Jump to Navigation

Facebook Connect

User login

Other Online Activities

Other Online Programs

The NLA partners with various medical education providers for special online program, satellite programs at meetings and more. The activities, sometimes accredited, are found here.


PCSK9 Inhibitors and CV Risk Reduction

In this two part educational series, entitled PCSK9 inhibitors and CV Risk Reduction: Understanding the Implications, experts discuss how Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors represent a promising strategy for decreasing CV risk in patients. In the first session, Drs. Michael Blaha and Michael Miller discuss The Emerging Role of PCSK9 Inhibitors. In part 2, Drs. Marc S. Sabatine, and James Underberg analyze the PCSK9 Outcome Studies. This series will improve clinician’s knowledge of the updated guidelines and the benefits/risks of newer therapies. It also provides clinicians with the tools to select the optimal LDL-C-lowering regimens, address concerns, and improve adherence, to more effectively lower cardiovascular risk in their patients.

Dyslipidemia: New Challenges and Emerging Options in Lowering CVD Risk- Activity 3: Incorporating PCSK9 Inhibitors Into the Management of Patients With Dyslipidemia

New 3-part online continuing education eCourse exploring the changing landscape of dyslipidemia management. Experts in lipidology examine treatment guidelines, strategies for CV risk reduction, and the value of collaborative care for patients.

Dyslipidemia: New Challenges and Emerging Options in Lowering CVD Risk- Activity 2: The PCSK9 Pathway and Other Emerging Options

New 3-part online continuing education eCourse exploring the changing landscape of dyslipidemia management. Experts in lipidology examine treatment guidelines, strategies for CV risk reduction, and the value of collaborative care for patients.

Lipid Management Beyond Statins: Biologic Basis, New Clinical Evidence and Strategies

For clinicians involved in managing dyslipidemia, including lipidologists, cardiologists, endocrinologists, internists, pharmacists, registered nurses, advance practice registered nurses, and associated allied health professionals.

Dyslipidemia: New Challenges and Emerging Options in Lowering CVD Risk - ACTIVITY 1: Challenges in Dyslipidemia Management

New 3-part online continuing education eCourse exploring the changing landscape of dyslipidemia management. Experts in lipidology examine treatment guidelines, strategies for CV risk reduction, and the value of collaborative care for patients.

Update on Hypertriglyceridemia: Clinical Relevance and Treatment Recommendations

What are the causes and risks of high triglycerides? What are the key lifestyle and pharmacologic strategies available to manage patients? View this free online program to learn more and claim 1.0 AMA PRA Category 1 Credit™.

Clinical Advancements in the Management of Familial Hypercholesterolemia

New treatments for FH change the face of this genetic disorder for patients the physicians who treat them.

 

 

4
Average: 4 (1 vote)
Publish Date: 
Thursday, August 1, 2013 - 10:00



by Dr. Radut.